A Multivalent Vaccine Containing Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae Antigens Elicits Strong Immune Responses and Promising Protection in Pigs

Actinobacillus pleuropneumoniae (App) and Mycoplasma hyopneumoniae (Mhp) cause porcine pleuropneumonia and mycoplasmal pneumonia, respectively, and have serious impacts on the swine industry because they retard the growth of pigs. To protect pigs against these diseases, we have developed a multivale...

Full description

Bibliographic Details
Main Authors: Hoai Thu Dao, Woo-Sung Shin, Van Tan Do, Quang Lam Truong, Jong-Young Choi, Tae-Wook Hahn
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2021-03-01
Series:Journal of Pure and Applied Microbiology
Subjects:
Online Access:https://microbiologyjournal.org/a-multivalent-vaccine-containing-actinobacillus-pleuropneumoniae-and-mycoplasma-hyopneumoniae-antigens-elicits-strong-immune-responses-and-promising-protection-in-pigs/
_version_ 1819137231535734784
author Hoai Thu Dao
Woo-Sung Shin
Van Tan Do
Quang Lam Truong
Jong-Young Choi
Tae-Wook Hahn
author_facet Hoai Thu Dao
Woo-Sung Shin
Van Tan Do
Quang Lam Truong
Jong-Young Choi
Tae-Wook Hahn
author_sort Hoai Thu Dao
collection DOAJ
description Actinobacillus pleuropneumoniae (App) and Mycoplasma hyopneumoniae (Mhp) cause porcine pleuropneumonia and mycoplasmal pneumonia, respectively, and have serious impacts on the swine industry because they retard the growth of pigs. To protect pigs against these diseases, we have developed a multivalent vaccine consisting of App bacterins, APP RTX toxins (Apx toxins), and Mhp bacterin and adhesin protein. This vaccine induced the production of higher levels of antibodies against App and Mhp than the commercial vaccine (Nisseiken Swine APM Inactivated Vaccine). Furthermore, the vaccine efficiently protected pigs against virulent App challenge, showing promise as an efficient vaccine for the prevention of two important respiratory diseases, porcine pleuropneumonia and mycoplasmal pneumonia.
first_indexed 2024-12-22T10:47:35Z
format Article
id doaj.art-d66b3feac23e45b9aa67ff06da886ff1
institution Directory Open Access Journal
issn 0973-7510
2581-690X
language English
last_indexed 2024-12-22T10:47:35Z
publishDate 2021-03-01
publisher Journal of Pure and Applied Microbiology
record_format Article
series Journal of Pure and Applied Microbiology
spelling doaj.art-d66b3feac23e45b9aa67ff06da886ff12022-12-21T18:28:54ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2021-03-0115116417410.22207/JPAM.15.1.11A Multivalent Vaccine Containing Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae Antigens Elicits Strong Immune Responses and Promising Protection in PigsHoai Thu Daohttps://orcid.org/0000-0002-2797-9955Woo-Sung Shinhttps://orcid.org/0000-0001-9061-7458Van Tan Dohttps://orcid.org/0000-0003-4512-7622Quang Lam Truonghttps://orcid.org/0000-0002-9403-2614Jong-Young Choihttps://orcid.org/0000-0002-2382-0701Tae-Wook Hahnhttps://orcid.org/0000-0002-3919-1153Actinobacillus pleuropneumoniae (App) and Mycoplasma hyopneumoniae (Mhp) cause porcine pleuropneumonia and mycoplasmal pneumonia, respectively, and have serious impacts on the swine industry because they retard the growth of pigs. To protect pigs against these diseases, we have developed a multivalent vaccine consisting of App bacterins, APP RTX toxins (Apx toxins), and Mhp bacterin and adhesin protein. This vaccine induced the production of higher levels of antibodies against App and Mhp than the commercial vaccine (Nisseiken Swine APM Inactivated Vaccine). Furthermore, the vaccine efficiently protected pigs against virulent App challenge, showing promise as an efficient vaccine for the prevention of two important respiratory diseases, porcine pleuropneumonia and mycoplasmal pneumonia.https://microbiologyjournal.org/a-multivalent-vaccine-containing-actinobacillus-pleuropneumoniae-and-mycoplasma-hyopneumoniae-antigens-elicits-strong-immune-responses-and-promising-protection-in-pigs/actinobacillus pleuropneumoniaemycoplasma hyopneumoniaemultivalent vaccineimmune responsesprotection efficacy
spellingShingle Hoai Thu Dao
Woo-Sung Shin
Van Tan Do
Quang Lam Truong
Jong-Young Choi
Tae-Wook Hahn
A Multivalent Vaccine Containing Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae Antigens Elicits Strong Immune Responses and Promising Protection in Pigs
Journal of Pure and Applied Microbiology
actinobacillus pleuropneumoniae
mycoplasma hyopneumoniae
multivalent vaccine
immune responses
protection efficacy
title A Multivalent Vaccine Containing Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae Antigens Elicits Strong Immune Responses and Promising Protection in Pigs
title_full A Multivalent Vaccine Containing Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae Antigens Elicits Strong Immune Responses and Promising Protection in Pigs
title_fullStr A Multivalent Vaccine Containing Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae Antigens Elicits Strong Immune Responses and Promising Protection in Pigs
title_full_unstemmed A Multivalent Vaccine Containing Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae Antigens Elicits Strong Immune Responses and Promising Protection in Pigs
title_short A Multivalent Vaccine Containing Actinobacillus pleuropneumoniae and Mycoplasma hyopneumoniae Antigens Elicits Strong Immune Responses and Promising Protection in Pigs
title_sort multivalent vaccine containing actinobacillus pleuropneumoniae and mycoplasma hyopneumoniae antigens elicits strong immune responses and promising protection in pigs
topic actinobacillus pleuropneumoniae
mycoplasma hyopneumoniae
multivalent vaccine
immune responses
protection efficacy
url https://microbiologyjournal.org/a-multivalent-vaccine-containing-actinobacillus-pleuropneumoniae-and-mycoplasma-hyopneumoniae-antigens-elicits-strong-immune-responses-and-promising-protection-in-pigs/
work_keys_str_mv AT hoaithudao amultivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT woosungshin amultivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT vantando amultivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT quanglamtruong amultivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT jongyoungchoi amultivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT taewookhahn amultivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT hoaithudao multivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT woosungshin multivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT vantando multivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT quanglamtruong multivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT jongyoungchoi multivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs
AT taewookhahn multivalentvaccinecontainingactinobacilluspleuropneumoniaeandmycoplasmahyopneumoniaeantigenselicitsstrongimmuneresponsesandpromisingprotectioninpigs